A groundbreaking study has identified a key genetic factor that allows bird flu viruses to persist and potentially cause severe illness in humans, even at fever-inducing temperatures that typically halt other viral infections. This discovery, led by researchers at the Universities of Cambridge and Glasgow, offers crucial insights into the persistent threat posed by avian influenza and its capacity to emerge as a pandemic pathogen. The findings, published on November 28 in the prestigious journal Science, reveal how a specific gene, when acquired by human flu strains, has historically contributed to the devastating impact of past pandemics.
The Resilience of Avian Influenza: A Threat Beyond Fever
For decades, scientists have grappled with the disconcerting ability of certain bird flu viruses to bypass one of the body’s most potent defenses: fever. While a human fever can elevate core body temperatures to as high as 41 degrees Celsius (105.8 degrees Fahrenheit), effectively hindering the replication of many pathogens, avian influenza viruses appear uniquely equipped to thrive under these conditions. This phenomenon has long been a critical question in virology, particularly given the high fatality rates observed in human infections with strains like H5N1, which have historically exceeded 40% mortality.
The new research pinpoints a specific gene, known as PB1, as a central player in this thermotolerance. The PB1 gene is fundamental for the virus’s ability to copy its genetic material within infected host cells, a process essential for viral replication. The study’s findings indicate that avian influenza viruses carrying an "avian-like" PB1 gene possess a remarkable resilience to heat. This resilience allows them to continue multiplying even when temperatures rise to levels that would typically suppress or eliminate human influenza viruses.
A Tale of Two Flu Strains: Temperature Sensitivity and Replication Niches
Understanding the difference in temperature sensitivity between avian and human influenza viruses is key to appreciating the significance of this discovery. Seasonal human influenza A viruses, the common culprits behind annual flu outbreaks, primarily replicate in the cooler upper airways of the respiratory tract. Here, temperatures hover around an average of 33 degrees Celsius (91.4 degrees Fahrenheit). While these viruses can spread to the warmer lower respiratory tract (closer to 37 degrees Celsius or 98.6 degrees Fahrenheit), their replication efficiency diminishes significantly at these higher temperatures. This physiological characteristic inherently limits their ability to cause widespread, severe illness in the core of the human body.
In stark contrast, avian influenza viruses often exhibit a preference for warmer environments. In their natural hosts, such as ducks and seagulls, these viruses can infect the gut and lower respiratory tract, where temperatures can reach a formidable 40-42 degrees Celsius (104-107.6 degrees Fahrenheit). This inherent adaptation to higher temperatures forms the basis of their ability to withstand the fever response in humans.
Unraveling the Mechanism: In Vivo Experiments Illuminate Fever’s Impact
While previous studies in laboratory cell cultures had suggested that bird flu viruses were more tolerant of fever-level temperatures than their human counterparts, the new research delves deeper by employing in vivo experiments with mice. These meticulously designed studies aimed to directly observe the interplay between fever and viral replication in a living organism.
The research team, comprising scientists from the University of Cambridge and the University of Glasgow, simulated fever conditions in mice infected with influenza viruses. Notably, mice do not spontaneously develop fevers when infected with influenza A viruses. To overcome this, the researchers artificially elevated the body temperatures of the mice by manipulating their environmental conditions. This allowed for a controlled observation of how viral replication responded to fever-like temperatures.
The results were striking. When the mice’s body temperatures were raised to fever levels, the human-origin influenza strain used in the experiment (a laboratory-adapted, non-pathogenic strain known as PR8) showed a dramatic reduction in its ability to replicate. This confirmed the long-held understanding that fever is an effective antiviral mechanism against common human flu viruses. However, the same temperature increases had a negligible effect on the avian influenza viruses.
A key finding emerged from these experiments: a mere 2-degree Celsius (3.6-degree Fahrenheit) increase in body temperature was sufficient to transform what would have been a potentially lethal infection with a human-origin influenza virus into a mild illness. Conversely, avian influenza viruses, even under these elevated temperatures, continued to pose a significant threat, demonstrating their inherent resistance to the body’s fever response.
The PB1 Gene: A Bridge for Pandemic Potential
The identification of the PB1 gene as the crucial factor in temperature resistance marks a significant breakthrough. The researchers discovered that avian-like PB1 genes conferred this heat tolerance, enabling the viruses to cause severe disease in mice even at fever temperatures. This finding carries profound implications, particularly in light of how influenza viruses can exchange genetic material.
Influenza viruses are notorious for their genetic plasticity. When both avian and human influenza viruses infect the same host – a phenomenon that can occur in intermediate hosts such as pigs – they can readily swap genetic segments. This reassortment process is a primary driver of influenza evolution and the emergence of novel, potentially pandemic strains.
The study highlights historical precedents for this genetic exchange. During the major flu pandemics of 1957 and 1968, evidence suggests that human flu viruses acquired the PB1 gene from circulating avian strains. This genetic acquisition likely played a critical role in the virulence and widespread dissemination of these pandemics, contributing to millions of deaths globally.
Dr. Matt Turnbull, the study’s lead author from the Medical Research Council Centre for Virus Research at the University of Glasgow, emphasized the ongoing threat posed by this gene-swapping ability. "The ability of viruses to swap genes is a continued source of threat for emerging flu viruses," Dr. Turnbull stated. "We’ve seen it happen before during previous pandemics, such as in 1957 and 1968, where a human virus swapped its PB1 gene with that from an avian strain. This may help explain why these pandemics caused serious illness in people."
He further underscored the importance of proactive surveillance. "It’s crucial that we monitor bird flu strains to help us prepare for potential outbreaks. Testing potential spillover viruses for how resistant they are likely to be to fever may help us identify more virulent strains."
The Persistent Threat of High Fatality Rates
While human infections with bird flu viruses are relatively infrequent, the consequences of such infections can be severe. Professor Sam Wilson, senior author of the study and from the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge, noted the alarming fatality rates observed in past avian influenza outbreaks in humans. "Thankfully, humans don’t tend to get infected by bird flu viruses very frequently, but we still see dozens of human cases a year. Bird flu fatality rates in humans have traditionally been worryingly high, such as in historic H5N1 infections that caused more than 40% mortality."
The ability of avian influenza viruses to overcome the body’s fever response is a significant factor contributing to their high virulence in humans. This underscores the critical need for robust global surveillance programs and preparedness strategies to mitigate the risk of future pandemics. "Understanding what makes bird flu viruses cause serious illness in humans is crucial for surveillance and pandemic preparedness efforts," Professor Wilson stated. "This is especially important because of the pandemic threat posed by avian H5N1 viruses."
Broader Implications for Public Health and Future Research
The findings of this study have far-reaching implications for public health strategies, particularly concerning fever management and pandemic preparedness. Historically, fever has been viewed as a symptom to be suppressed, with antipyretic medications like ibuprofen and aspirin commonly prescribed to alleviate discomfort and reduce fever. However, this research suggests that a more nuanced approach may be warranted.
The study’s authors noted that the findings could eventually influence treatment recommendations, although they stressed the need for further clinical research before any definitive changes are made. There is emerging clinical evidence suggesting that actively lowering fever might not always benefit patients and could, in some cases, inadvertently support the replication and spread of influenza A viruses in humans. This challenges conventional wisdom and opens avenues for re-evaluating the role of fever in fighting viral infections.
Furthermore, the discovery of the PB1 gene’s role in temperature resistance provides a crucial target for future antiviral drug development. By understanding the molecular mechanisms by which avian flu viruses evade fever, scientists can work towards developing therapies that specifically inhibit this resistance or enhance the body’s natural antiviral responses.
A Collaborative Effort Fueled by Global Support
This seminal research was made possible through substantial funding from several key organizations. The Medical Research Council provided primary funding, with additional crucial support coming from the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the European Research Council, the European Union Horizon 2020 initiative, the UK Department for Environment, Food & Rural Affairs, and the US Department of Agriculture. This multi-faceted financial backing underscores the global recognition of the importance of understanding and combating influenza threats.
The ongoing evolution of influenza viruses, coupled with their capacity for genetic reassortment and their ability to overcome fundamental host defenses, necessitates continued vigilance and investment in scientific research. The identification of the PB1 gene’s critical role in fever resistance represents a significant step forward in our understanding of avian influenza, offering valuable tools for surveillance, preparedness, and the ultimate goal of safeguarding global public health against the ever-present threat of novel influenza pandemics.
